Liver perfusion in sepsis, septic shock, and multiorgan failure

Anatomical Record

Volumn 291, Issue 6, 2008, Pages 714-720

  Spapen, Herbert ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Liver perfusion; Microcirculation; Organ failure; Sepsis; Septic shock

Indexed keywords

CARBON MONOXIDE; ENDOTHELIN 1; NITRIC OXIDE;

ANIMAL; HUMAN; LIVER; LIVER CIRCULATION; MICROCIRCULATION; MULTIPLE ORGAN FAILURE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEPSIS; SEPTIC SHOCK; SPLANCHNIC BLOOD FLOW;

ANIMALS; CARBON MONOXIDE; ENDOTHELIN-1; HUMANS; LIVER; LIVER CIRCULATION; MICROCIRCULATION; MULTIPLE ORGAN FAILURE; NITRIC OXIDE; SEPSIS; SHOCK, SEPTIC; SPLANCHNIC CIRCULATION;

EID: 45849115860     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.20646     Document Type: Article

References (91)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 29:1303-1310.
2. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E. 2002. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862-871.
3. Asfar P, Hauser B, Ivanyi Z, Ehrmann U, Kick J, Albicini M, Vogt J, Wachter U, Bruckner UB, Radermacher P, Bracht H. 2005. Low-dose terlipressin during long-term hyperdynamic porcine endotoxemia: effects on hepatosplanchnic perfusion, oxygen exchange, and metabolism. Crit Care Med 33:373-380.
4. Ayuse T, Brienza N, Revelly JP, O'Donnell CP, Boitnott JK, Robotham JL. 1995. Alterations in liver hemodynamics in an intact porcine model of endotoxin shock. Am J Physiol 268:H1106-H1114.
5. Bauer M, Zhang JX, Bauer I, Clemens MG. 1994. ET-1 induced alterations of hepatic microcirculation: sinusoidal and extrasinusoidal sites of action. Am J Physiol 267:G143-G149.
6. Bauer C, Walcher F, Kalweit U, Larsen R, Marzi I. 1997. Role of nitric oxide in the regulation of the hepatic microcirculation in vivo. J Hepatol 27:1089-1095.
7. Baveja R, Kresge N, Ashburn JH, Keller S, Yokoyama Y, Sonin N, Zhang JX, Huynh T, Clemens MG. 2002. Potentiated hepatic microcirculatory response to endothelin-1 during polymicrobial sepsis. Shock 18:415-422.
8. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr. 2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709.
9. Bilbault P, Lavaux T, Launoy A, Gaub MP, Meyer N, Oudet P, Pottecher T, Jaeger A, Schneider F. 2007. Influence of drotrecogin alpha (activated) infusion on the variation of Bax/Bcl-2 and Bax/Bcl-xl ratio in circulating mononuclear cells: a cohort study in septic shock patients. Crit Care Med 35:69-75.
10. G-monomethyl-L-arginine inhibits endotoxin-induced nitrite/ nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 48:565-569.
11. Boegehold MA. 1996. Shear-dependent release of venular nitric oxide: effect on arteriolar tone in rat striated muscle. Am J Physiol 271:H387-H395.
12. Boerma EC, van der Voort PHJ, Spronk PE, Ince C. 2007. Relationship between sublingual and intestinal microcirculatory perfusion in patients with abdominal sepsis. Crit Care Med 35:1055-1060.
13. Brinkmann A, Calzia E, Träger K, Radermacher P. 1998. Monitoring the hepato-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance. Intensive Care Med 24:542-556.
14. Britt RC, Devine A, Swallen KC, Weireter LS, Collins JN, Cole FJ, Britt LD. 2006. Corticosteroid use in the intensive care unit: at what cost? Arch Surg 141:145-149.
15. Cobb JP, Danner RL. 1996. Nitric oxide and septic shock. JAMA 275:1192-1196.
16. Creteur J, De Backer D, Vincent JL. 1999. A dobutamine test can disclose hepatosplanchnic hypoperfusion in septic patients. Am J Respir Crit Care Med 160:839-845.
17. Croner RS, Hoerer E, Kulu Y, Hackert T, Gebhard MM, Herfarth C, Klar E. 2006. Hepatic platelet and leukocyte adherence during endotoxemia. Crit Care 10:R15.
18. Da J, Chen L, Hedenstierna G. 2007. Nitric oxide up-regulates the glucocorticoid receptor and blunts the inflammatory reaction in porcine endotoxin sepsis. Crit Care Med 35:26-32.
19. Dahn MS, Lange MP, Wilson RF, Jacobs LA, Mitchell RA. 1990a. Hepatic blood flow and splanchnic oxygen consumption measurements in clinical sepsis. Surgery 107:295-301.
20. Dahn MS, Wilson RF, Lange MP, Stone A, Jacobs LA. 1990b. Hepatic parenchymal oxygen tension following injury and sepsis. Arch Surg 125:441-443.
21. De Backer D, Zhang H, Manikis P, Vincent JL. 1996. Regional effects of dobutamine in endotoxic shock. J Surg Res 65:93-100.
22. De Backer D, Creteur J, Noordally O, Smail N, Gulbis B, Vincent JL. 1998. Does hepato-splanchnic VO2/DO2 dependency exist in critically ill patients? Am J Respir Crit Care Med 157:1219-1225.
23. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. 2002. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 166:98-104.
24. De Backer D, Creteur J, Silva E, Vincent JL. 2003. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med 31:1659-1667.
25. De Backer D, Verdant C, Chierego M, Koch M, Gullo A, Vincent JL. 2006. Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis. Crit Care Med 34:1918-1924.
26. Dhainaut JF, Marin N, Mignon A, Vinsonneau C. 2001. Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 29:S42-S47.
27. Dhainaut JF, Yan SB, Margolis BD, Lorente JA, Russell JA, Freebairn RC, Spapen HD, Riess H, Basson B, Johnson G III, Kinasewitz GT. 2003. Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis. Thromb Haemost 90:642-653.
28. Downard PJ, Wilson MA, Spain DA, Matheson PJ, Siow Y, Garrison RN. 1997. Heme oxygenase-dependent carbon monoxide production is a hepatic adaptive response to sepsis. J Surg Res 71:7-12.
29. Esmon CT, Fukudome K, Mather T, Bode W, Regan LM, StearnsKurosawa DJ, Kurosawa S. 1999. Inflammation, sepsis and coagulation. Haematologica 84:254-259.
30. Fong Y, Marano MA, Moldawer LL, Wei H, Calvano SE, Kenney JS, Allison AC, Cerami A, Shires GT, Lowry SF. 1990. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 85:1896-1904.
31. Fries M, Weil MH, Sun S, Huang L, Fang X, Cammarata G, Castillo C, Tang W. 2006. Increases in tissue PCO2 during circulatory shock re.ect selective decreases in capillary blood flow. Crit Care Med 34:446-452.
32. Gregory SH, Wing EJ. 2002. Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J Leukocyt Biol 72:239-248.
33. Guerin JP, Levraut J, Samat-Long C, Leverve X, Grimaud D, Ichai C. 2005. Effects of dopamine and norepinephrine on systemic and hepatosplanchnic hemodynamics, oxygen exchange, and energy balance in vasoplegic septic patients. Shock 23:18-24.
34. Gundersen Y, Corso CO, Leiderer R, Dorger M, Lilleaasen P, Aasen AO, Messmer K. 1997. Use of selective and nonselective nitric oxide synthase inhibitors in rat endotoxemia: effects on hepatic morphology and function. Shock 8:368-372.
35. Gundersen Y, Corso CO, Leiderer R, Dorger M, Lilleaasen P, Aasen AO, Messmer K. 1998. The nitric oxide donor sodium nitroprusside protects against hepatic microcirculatory dysfunction in early endotoxaemia. Intensive Care Med 24:1257-1263.
36. Gutierrez G, Clark C, Brown SD, Price K, Ortiz L, Nelson C. 1994. Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med 150:324-329.
37. Hein OV, Ohring R, Schilling A, Oellerich M, Armstrong VW, Kox WJ, Spies C. 2004. N-acetylcysteine decreases lactate signal intensities in liver tissue and improves liver function in septic shock patients, as shown by magnetic resonance spectroscopy: extended case report. Crit Care 8:R66-R71.
38. Heller AR, Heller SC, Borkenstein A, Stehr SN, Koch T. 2003. Modulation of host defense by hydrocortisone in stress doses during endotoxemia. Intensive Care Med 29:1456-1463.
39. Higuchi H, Satoh T. 1997. Endothelin-1 induces vasoconstriction and nitric oxide release via endothelin ET (B) receptors in isolated perfused rat liver. Eur J Pharmacol 328:175-182.
40. Hiltebrand LB, Krejci V, Banic A, Erni D, Wheatley AM, Sigurdsson GH. 2000. Dynamic study of the distribution of microcirculatory blood flow in multiple splanchnic organs in septic shock. Crit Care Med 28:3233-3241.
41. Hsu BG, Lee RP, Yang FL, Harn HJ, Chen HI. 2006. Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats. Life Sci 79:2010-2016.
42. Huang T-P, Nishida T, Kamiike W, Kosaka H, Seiyama A, Morimoto Y, Tanaka S, Obunai S, Takei Y, Shiga T, Matsuda H. 1997. Role of nitric oxide in oxygen transport in rat liver sinusoids during endotoxemia. Hepatology 26:336-342.
43. Iba T, Kidokoro A, Fukunaga M, Nagakari K, Shirahama A, Ida Y. 2005. Activated protein C improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat lipopolysaccharide model. Crit Care Med 33:368-372.
44. Iwasashi H, Suzuki M, Unno M, Utiyama T, Oikawa M, Kundo N, Matsuno S. 2003. Inhibition of heme oxygenase ameliorates sepsis- induced liver dysfunction in rats. Surg Today 33:30-38.
45. Joly LM, Monchi M, Carriou A, Chiche JD, Bellenfant F, Brunet F, Dhainaut JF. 1999. Effect of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock. Am J Respir Crit Care Med 160:1983-1986.
46. Joyce DE, Grinnell BW. 2002. Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-kappa B. Crit Care Med 30:S288-S293.
47. Kaminski C, Grafadour P, Rimmele T, Goudable J, Chassard D. 2004. Early alteration of indocyanine green plasma disappearance rate in septic pigs. Anesthesiology 1001:A668.
48. Keller SA, Paxian M, Ashburn JH, Clemens MG, Huynh T. 2005. Kupffer cell ablation improves hepatic microcirculation after trauma and sepsis. J Trauma 58:740-749.
49. Kern H, Schroder T, Kaulfuss M, Martin M, Kox W, Spies C. 2001. Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients. Crit Care Med 29:1519-1525.
50. Kimura S, Yoshioka T, Shibuya M, Sakano T, Tanaka R, Matsuyama S. 2001. Indocyanine green elimination rate detects hepatocellular dysfunction early in septic shock and correlates with survival. Crit Care Med 29:1159-1163.
51. Krejci V, Hiltebrand LB, Erni D, Sigurdsson GH. 2003. Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock. Crit Care Med 31:203-210.
52. Lehmann C, Taymoorian K, Wauer H, Krausch D, Birnbaum J, Kox WJ. 2000. Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock. Intensive Care Med 26:1557-1560.
53. Lehmann C, Meissner K, Knock A, Diedrich S, Pavlovic D, Gründling M, Usichenko T, Wendt M, Birnbaum J. 2006. Activated protein C improves intestinal microcirculation in experimental endotoxaemia in the rat. Crit Care 10:R157.
54. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzueto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Arneson C, Grove G, Grossman S, Grover R. 2004. Multiple-center, randomized, placebo-controlled doubleblind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21-30.
55. Lundberg J, Ahlborg G, Hemsen A, Nisell H, Lunell NO, Pernon J, Rudehill A, Weitzberg E. 1991. Evidence for release of endothelin- 1 in pigs and humans. J Cardiovasc Pharmacol 17:S350-S353.
56. Macedo MP, Lautt WW. 1996. Shear-induced modulation by nitric oxide of sympathetic nerves in the superior mesenteric artery. Can J Physiol Pharmacol 74:692-700.
57. Marik PE, Varon J. 1998. The hemodynamic derangements in sepsis: implications for treatment strategies. Chest 114:854-860.
58. Martikainen TJ, Uusaro A, Tenhunen JJ, Ruokonen E. 2004. Dobutamine compensates deleterious hemodynamic and metabolic effects of vasopressin in the splanchnic region in endotoxin shock. Acta Anaesthesiol Scand 48:935-943.
59. Mathura KR, Vollebregt KC, Boer K, De Graaff JC, Ubbink DT, Ince C. 2001. Comparison of OPS imaging and conventional capillary microscopy to study the human microcirculation. J Appl Physiol 91:74-78.
60. Miura S, Fukumura D, Kurose I, Higuchi H, Kimura H, Tsuzuki Y, Shigematsu T, Han JY, Tsuchiya M, Ishii H. 1996. Roles of ET-1 in endotoxin-induced microcirculatory disturbance in rat small intestine. Am J Physiol 271:G461-G469.
61. Molnar Z, Shearer E, Lowe D. 1999. N-acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective randomized, placebo-controlled study. Crit Care Med 27: 1100-1104.
62. Navaratnam RL, Morris SE, Traber DL, Flynn J, Woodson L, Linares H, Herndon DN. 1990. Endotoxin (LPS) increases mesenteric vascular resistance (MVR) and bacterial translocation (BT). J Trauma 30:1104-1113.
63. Nishida J, McCuskey RS, McDonnell D, Fox ES. 1994. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol 267:G1135-G1141.
64. Pastor CM, Payen DM. 1994. Effect of modifying nitric oxide pathway on liver circulation in a rabbit endotoxin shock model. Shock 2:196-202.
65. Pastor CM, Billiar TR, Losser MR, Payen DM. 1995a. Liver injury during sepsis. J Crit Care 10:183-197.
66. Pastor CM, Losser MR, Payen D. 1995b. Nitric oxide donor prevents hepatic and systemic perfusion decrease induced by endotoxin in anesthetized rabbits. Hepatology 22:1547-1553.
67. Peake SL, Moran JL, Leppard PI. 1996. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med 24:1302-1310.
68. Peralta C, Rull R, Rimola A, Deulofeu R, Rosello-Catafau J, Gelpi E, Rodes J. 2001. Endogenous nitric oxide and exogenous nitric oxide supplementation in hepatic ischemia-reperfusion injury in the rat. Transplantation 71:529-536.
69. Preiser JC, Zhang H, Vray B, Hrabak A, Vincent JL. 2001. Time course of inducible nitric oxide synthase activity following endotoxin administration in dogs. Nitric Oxide 5:208-211.
70. Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, Spies C. 2000. N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study. Crit Care Med 28:3799-3807.
71. Reinelt H, Radermacher P, Fisher G, Geisser W, Wachter U, Wiedeck H, Georgieff M, Vogt J. 1997. Effects of a dobutamineinduced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 86:818-824.
72. Reinelt H, Radermacher P, Kiefer P, Fisher G, Wachter U, Vogt J, Georgieff M. 1999. Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med 27:325-331.
73. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. 2001. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377.
74. Saetre T, Gundersen Y, Thiemermann C, Lilleaasen P, Aasen AO. 1998. Aminoethyl-isothiourea, a selective inhibitor of inducible nitric oxide synthase activity, improves liver circulation and oxygen metabolism in a porcine model of endotoxemia. Shock 9:109-115.
75. Sakamoto M, Veno T, Kin M, Ohira H, Torimura T, Inuzuka S, Sata M, Tanikawa K. 1993. Ito cell contraction in response to endothelin- 1 and substance P. Hepatology 18:978-983.
76. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. 2004. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 32:1825-1831.
77. Schmidt H, Schmidt W, Muller T, Bohrer H, Gebhard MM, Martin E. 1997. N-acetylcysteine attenuates endotoxin-induced leukocyte- endothelial cell adhesion and macromolecular leakage in vivo. Crit Care Med 25:858-863.
78. Shieh P, Zhou M, Ornan DA, Chaudry IH, Wang P. 2000. Upregulation of inducible nitric oxide synthase and nitric oxide occurs later than the onset of the hyperdynamic response during sepsis. Shock 13:325-329.
79. Smithies M, Yee TH, Jackson L, Beale R, Bihari D. 1994. Protecting the gut and the liver in the critically ill: effects of dopexamine. Crit Care Med 22:789-795.
80. Spapen H, Zhang H, Wisse E, Baekeland M, Seynaeve C, Eddouks M, Vincent JL. 1999. The 21-aminosteroid U74389G enhances hepatic blood flow and preserves sinusoidal endothelial cell function and structure in endotoxin-shocked dogs. J Surg Res 86:183-191.
81. Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-Van Straaten HM, Zandstra DF. 2002. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 360:1395-1396.
82. Spronk PE, Zandstra DF, Ince C. 2004. Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care 8:462-468.
83. Suematsu M, Goda N, Sano T, Kashiwagi S, Egawa T, Shinoda Y, Ishimura Y. 1995. Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. J Clin Invest 96:2431-2437.
84. Tighe D, Moss R, Heywood G, Al-Saady N, Webb A, Bennett D. 1995. Goal-directed therapy with dopexamine, dobutamine and volume expansion: effects of systemic oxygen transport on hepatic ultrastructure in porcine sepsis. Crit Care Med 23:1997-2007.
85. Unger LS, Cryer HM, Garrison RN. 1989. Differential response of the microvasculature in the liver during bacteremia. Circ Shock 29:335-344.
86. Uusaro A, Ruokonen E, Takala J. 1995. Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green. Cardiovasc Res 30:106-112.
87. van Haren FM, Rozendaal FW, Van der Hoeven JG. 2003. The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock. Chest 124:2256-2260.
88. Wang Y, Lawson JA, Jaeschke H. 1998. Differential effect of 2-aminoethyl- isothiourea, an inhibitor of the inducible nitric oxide synthase, on microvascular blood flow and organ injury in models of hepatic ischemia-reperfusion and endotoxemia. Shock 10:20-25.
89. Wright CE, Rees DD, Moncada S. 1992. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26:48-57.
90. Wunder C, Brock RW, Frantz S, Gottsch W, Morawietz H, Roewer N, Eichelbronner O. 2005. Carbon monoxide, but not endothelin-1, plays a major role for the hepatic microcirculation in a murine model of early systemic inflammation. Crit Care Med 33:2323-2331.
91. Zhang H, Spapen H, Nguyen DN, Rogiers P, Bakker J, Vincent JL. 1995. Effects of N-acetyl-L-cysteine on regional blood flow during endotoxic shock. Eur Surg Res 27:292-300.